@article{8906ba23cee244f0b284fd37a86954be,
title = "Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years",
author = "Kerri Wazny and Alvin Zipursky and Robert Black and Valerie Curtis and Christopher Duggan and Richard Guerrant and Myron Levine and Petri, \{William A.\} and Mathuram Santosham and Rebecca Scharf and Sherman, \{Philip M.\} and Evan Simpson and Mark Young and Bhutta, \{Zulfiqar A.\}",
note = "Funding Information: VC is the principal investigator on a research grant from Unilever Plc that aims to understand behaviour associated with handwashing with soap. ML holds a patent as co-inventor of live oral cholera vaccine strain CVD 103-HgR, which has been licensed by the vaccine company PaxVax, who are supporting the clinical development program towards national regulatory agency licensure of the vaccine. MS is on the editorial board of PLOS Medicine. PMS sits on the Medical Scientific Advisory Board for Alberta Inflammatory Bowel Disease Research Consortium. PMS sits on Medical Advisory Boards for Abbott Nutrition, Mead Johnson Nutrition, and Proctor and Gamble; PMS sits on the Research Advisory Board for Antibe Therapeutics and is a stockholder. PMS also currently holds a research contract from Institut Rosell-Lallemand Inc. (Montreal, Quebec, Canada) to study the effectiveness of a short-chain fructo-oligosaccharide (sc-FOS) prebiotic preparation in ameliorating intestinal epithelial injury in response to bacterial enteric pathogens using both polarized model epithelia in tissue culture and a murine model of colitis, undertaken in the Research Institute at the Hospital for Sick Children in Toronto, Canada where the funds are held in a research funding account. The studies are also supported by research funding from the Canadian Institutes of Health Research (2008–2013) and previously by a Fay Shapiro-Cutler grant-in-aid from the Crohn's and Colitis Foundation of Canada (2007–2010). ZAB is on the editorial board of PLOS Medicine, and is the principal investigator of the grant from the Bill \& Melinda Gates Foundation to coordinate the development of the Global Action Plan for Pneumonia and Diarrhoea. All other authors report no competing interests. ",
year = "2013",
doi = "10.1371/journal.pmed.1001446",
language = "English (US)",
volume = "10",
journal = "PLoS Medicine",
issn = "1549-1277",
publisher = "Public Library of Science",
number = "5",
}